News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Wednesday, April 01, 2015

Top Breaking News

News from Around the Web
Eek! How Your Face Reveals Your Body's Real Age, Shanghai Institutes Of Biological Sciences Study
Facebook App Encourages Individuals To Get In Touch With Their DNA, University of Michigan Reveals
University of York Researchers Discover Bacterial Genetic Pathway Involved In Body Odor Production
Repurposed Experimental Cancer Drug Restores Brain Function In Mouse Models Of Alzheimer’s Disease, Yale University Study
As Deadly Pig Virus Wanes, Bacon Prices Shrink, USDA Reveals
Pharma’s Comeback Deals Keep Drug M&A On Track To Reach Records
Date Syrup Shows Promise For Fighting Bacterial Infections, Cardiff Metropolitan University Study
New Cancer Drugs "Vastly Overestimated"
An Apple A Day Won’t Keep The Doctor Away But Maybe The Pharmacist, University of Michigan Study
Stop Blaming The Moon, Says University of California, Los Angeles (UCLA) Scientist

Press Releases
Botox Biotech Anterios Files For A $58 Million IPO
Takeda (TKPYY) Offers $2.2 Billion To Settle Actos Drug Cases
Kala Pharmaceuticals KPI-121 Meets All Primary Endpoints In Phase III For Cataract Surgery
Kala Pharmaceuticals KPI-121 Meets Primary Sign Endpoint In Phase II For Dry Eye Disease
RegeneRx Biopharmaceuticals, Inc. (RGRX)'s RGN-259 Meets Key Efficacy Objectives In Phase II Clinical Trial In Patients With Severe Dry Eye Reported In Current Issue Of Cornea
Myriad Genetics, Inc. (MYGN) And AstraZeneca PLC (AZN) Expand Research Collaboration On Lynparza
Neurocrine Biosciences, Inc. (NBIX) And Mitsubishi Tanabe Pharma Corporation Announce Agreement To Develop And Commercialize VMAT2 Inhibitor NBI-98854 For Movement Disorders In Japan And Other Select Asian Markets
Receptos (RCPT) Completes Enrollment Of RADIANCE Phase 3 Trial Of Ozanimod In Relapsing Multiple Sclerosis
Pivotal Pharmacokinetic Study Of Innocoll, Inc. (INNL)'s Xaracoll(R) Supports Use Of 300 Mg Dose For Phase 3 Clinical Studies In Post-Operative Pain
Nymox Pharmaceutical (NYMX) Announces Phase 3 BPH Studies
CEL-SCI (CVM) Reports 3rd Consecutive Month Of Record Patient Enrollment In 2015 For Its Phase III Head And Neck Cancer Trial
Anergis Announces Completion Of Treatment In AllerT Phase II Dose-Ranging Trial
Servier Initiates Phase 2 Study Of Gevokizumab In Patients With Diabetic Nephropathy
NeuroDerm Ltd. (NDRM) To Announce Updated Topline Results Of Phase II Study Of Continuous, Subcutaneously-Delivered Levodopa/Carbidopa For The Treatment Of Parkinson's Disease At The 67th Annual Meeting Of The American Academy of Neurology
NIH Funds Study Of Fully Personalized Immunotherapy AGS-004 Combined With A Latency Reversing Therapy For The Treatment Of HIV
Pharmacyclics (PCYC) Release: Solid Tumor Study Investigating Ibrutinib (IMBRUVICA) In Combination With Anti-PD-L1 Antibody (MEDI4736) Commences In Patients With Relapsed/Refractory Non-Small Cell Lung, Breast And Pancreatic Cancers
Hutchison Medipharma's Cancer Drug Meets Endpoint In Phase II Trial
Sigma-Tau Pharmaceuticals Receives Orphan Drug Designation For STP-206 For Prevention Of Necrotizing Enterocolitis
Burzynski Research Institute Announces Publication Of Phase II Results In Adults With Newly-Diagnosed Anaplastic Astrocytoma
Dyax Corp. (DYAX) Announces Positive Results From Phase Ib Clinical Trial Of DX-2930
Oramed Pharmaceuticals Inc. (ORMP) Enrolls First Patient In Its Glucose Clamp Study For Oral Insulin
Idera Pharmaceuticals, Inc. (IDRA) Announces FDA Orphan Drug Designation For IMO-8400 For The Treatment Of Diffuse Large B-Cell Lymphoma
Immune Design Corporation (IMDZ) Announces Positive Topline Data From Three Phase 1 Clinical Trials Of Immuno-Oncology Agents
ESSA Pharma Announces Filing Of Investigational New Drug Application For EPI-506
Prescient Therapeutics Receives Approval From U.S. FDA To Transfer IND Sponsorship For Lead Drug Candidate PTX-200
Corbus Pharmaceuticals, Inc. Announces Presentation Of Positive Data On Anti-Fibrotic Effects Of Resunab In A Preclinical Model Of Lung Fibrosis At The Experimental Biology 2015 Scientific Conference
Rhinomed (ASX:RNO) To Initiate Nation Wide Sleep Study This Saturday Night
University of Cincinnati Release: Pulmonary Embolism Risk Scoring Could Guide Treatment, Ease Burden On EDs
Valeant (VRX) Completes Acquisition Of Salix (SLXP)
Dr. Reddy's Laboratories Ltd. (RDY) To Acquire Select Portfolio Of The Established Products Business Of UCB In India
Brickell Biotech Signs Exclusive License And Development Agreement For BBI-4000 With Kaken Pharmaceuticals
Stellar Biotechnologies, Inc. And Neovacs SA Expand KLH Supply Relationship
Panther Biotechnology Announces Exclusive License Agreement With Northwestern University
Portage Biotech's Biohaven Announces Agreement With inVentiv Health (VTIV)
Covance Inc. (CVD) And Sihuan Pharmaceutical Initiate Partnership In Preclinical And Clinical Portfolio Development
VLP Therapeutics Enters Collaboration With Institute Of Tropical Medicine, Nagasaki University
Teijin Limited Signs Sales Agreement For New Anti-inflammatory Analgesic Patch Formulation
Shire (SHPGY) Release: Natpara (Parathyroid Hormone) For Injection Now Available In The U.S.
Merck & Co. (MRK)'s HPV Vaccine, GARDASIL9, Now Available In Canada
Meagan Medical Announces Issuance Of A Key U.S. Patent For A Disruptive Chronic Pain Treatment Using Spinal Cord Stimulation
Acucela Granted New Patent Covering Method Of Use For Emixustat Hydrochloride
Kamada Ltd. (KMDA) Receives Allowance For Key Canadian Patent For Large Scale Production And Use Of Proprietary Alpha-1 Proteinase Inhibitor
aTyr Pharma Secures $76 Million In Series E Financing
Redemption Of All Of Salix (SLXP)'s Outstanding 6.00% Senior Notes Due 2021
Cardio3 BioSciences Announces Intention To Conduct A Registered Public Offering In The United States
Valeant (VRX) Completes Tender Offer For Salix (SLXP)
Novavax, Inc. (NVAX) Announces Closing Of Public Offering
Coherus Biosciences Prices Upsized Public Offering Of $120.0 Million Of Common Stock
Trillium Therapeutics Inc. Announces Pricing Of Public Offering Of Securities
Egalet Announces Proposed $60 Million Offering Of Convertible Senior Notes Due 2020
Mylan N.V. Announces Pricing Of Secondary Public Offering Of A Portion Of Abbott (ABT)'s Ordinary Shares
Omnicell Regains Nasdaq Listing Compliance
Inogen (INGN)To File Form 12b-25 With Securities And Exchange Commission
Grifols (GRFS) 2014 Annual Report On Form 20-F Filed With The SEC On April 1, 2015
TxCell 2014 Results: Strengthening Of Cash Position And Development Of Astria Product Platform
PlasmaTech Biopharmaceuticals Provides Strategic Update For 2015 And Review Of 2014 Acheivements
Flex Pharma (FLKS) Added To Russell 3000®, Russell 2000, And Russell Microcap Indices
De Blasio Administration Launches Major Funding Initiative To Create Thousands Of Jobs In City's Life Sciences Sector
InVivo Therapeutics Corporation (NVIV) Announces New Clinical Trial Site For Neuro-Spinal Scaffold
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
The Medicines Company (MDCO) Settles Angiomax (Bivalirudin) Patent Litigation With Sun
Sysmex America, Inc. Receives U.S. Department Of Defense Accreditation For WAM Middleware Solution
DATATRAK International, Inc. (DATA) Office Expansion Enhances Customer Experience
AstraZeneca PLC (AZN) To Implement D-Wise Clinical Trial De-Identification Software To Protect Patient Privacy During Clinical Trial Data Transparency Initiatives.
TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available
Celprogen Introduces Stem Cell Derived Conditioned Media As An Active Ingredient For Regenerative Cosmetic Industry Tested And Validated In Cosmetic Products For A Decade
Abbott (ABT) Hosts Conference Call For First-Quarter Earnings
Arno Therapeutics Reports Fourth Quarter 2014 Financial And Business Update
CytoSorbents, Inc. Reports Record 2014 Revenue
GeneNews (GEN.TO) Announces Q4 And Full Year 2014 Financial Results
International Isotopes (INIS) Announces 2014 Year End Financial Results
Inotek Pharmaceuticals Corporation Reports 2014 Financial Results
Immune Design Corporation (IMDZ) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update
Nuo Therapeutics Reports Full-Year 2014 Financial Results
PGI Reports Preliminary Full Year and Fourth Quarter 2014 Results
Pressure BioSciences, Inc. (BBII) Reports Fiscal Year 2014 Financial Results And Provides Business Update
ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2014
Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results
ImmunoGen (IMGN) Appoints Anna Berkenblit, MD, MMSc Vice President And Chief Medical Officer
Immunocore Limited Appoints Dr. Christina Coughlin As Chief Medical Officer
Otonomy, Inc. (OTIC) Appoints Dean Hakanson, M.D., As Chief Medical Officer
Centene Corporation Appoints Marcela Manjarrez-Williams As Senior Vice President And Chief Communications Officer
Sarepta (SRPT) Appoints Edward Kaye, M.D., As Interim CEO; Company On Track With Clinical And Regulatory Plans For Investigational Duchenne Muscular Dystrophy Drugs
Galmed Pharmaceuticals Announces The Appointment Of George Tonelli As Vice President Of Clinical Operations
EMD Serono Appoints Frederick E. Munschauer M.D., FAAN To Vice President Of Medical Affairs, Neurology And Immunology
Evofem, Inc. Appoints Dr. David Friend As Senior Vice President Of Product Development
Corium International, Inc. Announces Appointment Of Eric H. Bjerkholt To Board Of Directors
Blaze Bioscience Inc. Appoints Jan Öhrström, M.D., To Its Board Of Directors
Clinigen Succession Planning - Board Change
DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., To The Board Of Directors
Iroko Pharmaceuticals Appoints New Member To Company’s Board Of Directors
Karyopharm Appoints Mikael Dolsten, MD, Phd To Its Board Of Directors
Midatech Pharma PLC Board Change
Nexvet Biopharma Appoints Dr. George Gunn As Chairman
RRD International, LLC Hires Former FDA Deputy Director Of Anti-Infective Products Division
Vectura Group plc (VEC.L) Release: Appointment Of Non-Executive Director
Ximbio Expands Team
INC Research, Inc. (INCR) And Society For Clinical Research Sites Reach Milestone Of More Than 100 Scholarships Awarded To Clinical Research Sites Worldwide
Janssen Therapeutics Announces Support For Organizations Focused On Improving Care And Treatment For People Who Inject Drugs Living With HIV And/Or Hepatitis C
Oxis Biotech Discusses Its Immunotherapeutic Development Strategy
Touro University Release: Harmful Effects Of Fructose Can Be Quickly Reversed
Chardan Capital Issues Industry Note Covering Spherix (SPEX)
Organovo Describes First Fully Cellular 3d Bioprinted Kidney Tissue
Chairman Of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth Of Shares Citing Confidence In Company's Development In Online And Offline Macrohealth Business
MACROGEN Renews CI After 19 Years, Making A Great Leap Forward To Be A Global Leader Of Personalized Genomic Medicine
New PHT Corporation Webinar Presents Research On Patient Engagement, Compliance And Preferences For eCOA Technologies , BYOD And mHealth
Chiltern International Ltd. Ranks Among Top CROs In Global Survey Of Clinical Research Sites
Synthetic Biologics, Inc. (SYN)' SYN-004 Clinical Data For Protection Of Microbiome Selected For Poster Presentation At American Society of Microbiology 2015
UBM China Release: MEDITEXPO JIANGSU 2015 To Be Held In Changzhou In September
Celator Pharmaceuticals, Inc. To Present At 14th Annual Needham Healthcare Conference
Deciphera Pharmaceuticals To Present At The 14th Annual Needham Healthcare Conference
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Present At Needham Healthcare Conference
UBM Asia Limited Release: MEDTEC & NAMSA Co-organize BPMDS Symposium China
MiMedx To Present At The 14th Annual Needham Healthcare Conference